Category: Leukemia

Upstate dad organizing Ultimate Hike to help cure cancer

An Upstate father is preparing to lead a group of hikers on The Ultimate Hike – a one-day, 28-mile trek on the Foothills Trail to benefit families with children battling cancer. “On January 25, 2011, we heard those words that no parent ever wants to hear, ‘your child has cancer,'” Jeff Busby stated in a news release.

Cancer fight ends tragically for 7-year-old boy

Joshua’s mother, Lia Weekes, donated bone marrow to her son, but doctors said his chances would have been better with an external donor who was a closer match in ethnic makeup. Joshua Weekes’ life was cut early, but family and friends say his kindness, laughter and smarts will be remembered forever.

The Value of Survival Gains in Myelodysplastic Syndromes

ABSTRACT Objectives: To measure the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes . Study Design: Retrospective study of patients diagnosed with MDS in the Surveillance, Epidemiology and End Results Program registry, clinical trial evidence for MDS therapies, and claims data.

10x Genomics Announces Publication of Study in Nature Communications…

This powerful new technology provides robust single-cell expression measurements, allowing the discovery of gene expression dynamics and molecular profiling of individual cell types at scale. The study, titled “Massively parallel digital transcriptional profiling of single cells,” was published in Nature Communications and was co-authored with researchers from the Fred Hutchinson Cancer Research Center .

Camp Lejeune veterans eligible for disability

The US Department of Veterans Affairs is proposing to grant disability benefits for eight diseases for any active-duty, reserve or National Guard personnel who served at least 30 days at Camp Lejeune, North Carolina, between Aug. 1, 1953 and Dec. 31, 1987. Widows of these service personnel who died as a result of being afflicted with these diseases will also be eligible for death benefits, including a monthly stipend of approximately $1,250 and possible free health insurance for life.

new US agrees to pay billions to Marines affected by toxic water

The Obama administration has agreed to provide disability benefits totaling more than $2 billion to veterans who had been exposed to contaminated drinking water while assigned to Camp Lejeune in North Carolina. Beginning in March, the cash payouts from the Department of Veterans Affairs may supplement VA health care already being provided to eligible veterans stationed at the Marine base for at least 30 days cumulative between Aug. 1, 1953, and Dec. 31, 1987.

US agrees to pay billions to Marines affected by toxic water

After years of wait, veterans who had been exposed to contaminated drinking water while assigned to Camp Lejeune in North Carolina may now be able to receive a portion of government disability benefits totaling more than $2 billion. Beginning in March, the cash payouts from the Department of Veterans Affairs may supplement VA health care already being provided to eligible veterans stationed at the Marine base for at least 30 days cumulative between Aug. 1, 1953, and Dec. 31, 1987.

Obama administration to pay billions to Marines affected by toxic water

The Obama administration has agreed to provide disability benefits totaling more than $2 billion to veterans who had been exposed to contaminated drinking water while assigned to Camp Lejeune in North Carolina. Beginning in March, the cash payouts from the Department of Veterans Affairs may supplement VA health care already being provided to eligible veterans stationed at the Marine base for at least 30 days cumulative between Aug. 1, 1953, and Dec. 31, 1987.

Selective laser nano-thermolysis of human leukemia cells with…

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Background and Objective Previously reported studies on laser nano-thermolysis of cancerous cells demonstrated insufficient efficacy and specificity of malignant cell damage.

Cells dripped into brain help fight a cancer

… the Food and Drug Administration, the California Institute for Regenerative Medicine and the National Institutes of Health. Some authors get royalties from pending patents or money from Mustang Bio, Inc., which has licensed some of the technology. …

Possible treatment for pre-malignant bone marrow disorders

Washington D.C. [USA], Dec. 31 : A team of US researchers suggested a new mechanism that controls blood cell function and several possible molecular targets for treating blood cancer. [NK Health] The researchers found that over expression of a protein, called TRAF6 , in blood cells drives the onset of myelodysplasia syndromes – a group of pre-malignant disorders in which bone marrow does not produce enough healthy blood cells.

Mesa cancer survivor graduates from HS

A student who made national news after not being allowed to graduate after battling cancer has finally gotten the chance to get his diploma. Dwyer withdrew from school during his junior year to receive a bone marrow transplant for leukemia.

FDA puts Seattle Genetics drug trials on hold after 4 deaths

Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies. Six patients with acute myeloid leukemia , a type of blood cancer, have been identified with liver toxicity and four have died, the company said on Tuesday.

Returning home

Brother and sister, Dave and Charlene Buescher, stand together in front of Essentia Health’s Christmas tree with presents flown to International Falls from Duluth’s St. Mary’s hospital. Brother and sister, Dave and Charlene Buescher, stand together in front of Essentia Health’s Christmas tree with presents flown to International Falls from Duluth’s St. Mary’s hospital.

Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424

Threshold Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for cancer, today announced that it has entered into a collaboration with the National Cancer Institute , part of the National Institutes of Health , to study TH-3424, the company’s new drug candidate for the treatment of cancer. The collaboration will explore the effects of TH-3424 against T-cell acute lymphoblastic leukemia xenograft cell lines with high AKR1C3 expression.

Boy in remission from cancer helps spread Christmas cheer to kids still fighting

After her son young son, P.J. Moura, battled childhood cancer for three years, Sarah Montgomery realized the thing that made him happy in those days in the hospital was when people brought him toys. Now in remission, P.J., his mother and a group of volunteers – brought together by a Facebook post by Montgomery - came together over the weekend to fill stockings and wrap presents that will be presented to children still battling cancer.